A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: Treatment with a combination of amphotericin B and 5-flucytosine

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 560-564

  Park, S G ^a   Oh, S H ^a   Suh, S B ^b   Lee, K H ^a   Chung, Kee Yang ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

5 flucycosine; Amphotericin B; Chromoblostomycosis; Phialophora verrucosa; Unexposed area

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE; ITRACONAZOLE;

ADULT; ARTICLE; BREAST; CASE REPORT; CHROMOMYCOSIS; CLADOSPORIUM; CLADOSPORIUM CARRIONI; CLINICAL FEATURE; FEMALE; FONSECAEA; FONSECAEA COMPACTA; FONSECAEA PEDROSOI; FOOT; FUNGUS; HUMAN; HYPHOMYCETES; INOCULATION; LEG; OCCUPATIONAL EXPOSURE; PHIALOPHORA VERRUCOSA; PRIORITY JOURNAL; RHINOCLADIELLA CERPHILUM; SCLERODERMA; SKIN INJURY;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BREAST DISEASES; CHROMOBLASTOMYCOSIS; DERMATOMYCOSES; DRUG THERAPY, COMBINATION; FEMALE; FLUCYTOSINE; HUMANS; PHIALOPHORA;

EID: 17444413034     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06424.x     Document Type: Article

References (27)

1. Milam CP, Fenske NA. Chromoblastomycosis. Dermatol Clin 1989; 7:219-25.
2. McGinnis MR, Hilger AE. Infections caused by black fungi. Arch Dermatol 1987; 123:1300-2.
3. Dixon DM, Polak A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34:1-18.
4. Elgart G. Chromoblastomycosis. Dermatol Clin 1996; 14:77-83.
5. Lundstrom TS, Fairfax MR, Dugan MC et al. Phialophora verrucosa infection in a BMT patient. Bone Marrow Transplant 1997; 20:789-91.
6. Ho RH, Bernard PJ, McClellan KA. Phialophora mutabilis keratomycosis. Am J Ophthalmol 1991; 112:728-9.
7. Juma A. Phialophora richardsiae endocarditis of aortic and mitral valves in a diabetic man with a porcine mitral valve. J Infect 1993; 27:173-5.
8. Gezuele E, Mackinnon JE, Conti-Diaz IA. The frequent isolation of Phialophora verrucosa and Phialophora pedrosoi from natural sources. Sabouraudia 1972; 10:266-73.
9. Rubin HA, Bruce S, Rosen T, McBride ME. Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis. J Am Acad Dermatol 1991; 25:951-4.
10. Fukushiro R. Chromoblastomycosis in Japan. Int J Dermatol 1983; 22:221-9.
11. Morris A, Schell WA, McDonagh D et al. Pneumonia due to Fonsecaea pedrosoi and cerebral abscesses due to Emericella nidulans in a bone marrow transplant recipient. Clin Infect Dis 1995; 21:1346-8.
12. Larone DH. Dematiaceous fungi. In: Medically Important Fungi. A Guide to Identification (Larone DH, ed.). Washington: ASM Press, 1995; 121-59.
13. Fincher RME, Fisher JF, Padhye AA et al. Subcutaneous phaeohyphomycotic abscess caused by Phialophora parasitica in a renal allograft recipient. J Med Vet Mycol 1988; 26:311-15.
14. DiSalvo AF, Chew WH. Phialophora gougerotii: an opportunistic fungus in a patient treated with steroids. Sabouraudia 1968; 6:241-5.
15. Duggan JM, Kauffman WCA. Phialophora verrucosa infection in an AIDS patient. Mycoses 1995; 38:215-18.
16. Smith CH, Barker JN, Hay RJ. A case of chromoblastomycosis responding to treatment with itraconazole. Br J Dermatol 1993; 128:436-9.
17. Queiroz-Telles F, Purim KS, Fillus JN et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992; 31:805-12.
18. Yu R. Successful treatment of chromoblastomycosis with itraconazole. Mycoses 1995; 38:79-83.
19. Guerriero C, De Simone C, Tulli A. A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole. Eur J Dermatol 1998; 8:167-8.
20. Tuffanelli L, Milburn P. Treatment of chromoblastomycosis. J Am Acad Dermatol 1990; 23:728-32.
21. demons KV, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42:899-902.
22. Patel R. Antifungal agents. Part I. Amphotericin B preparations and flucytosine. Mayo Clin Proc 1998; 76:1205-25.
23. Goldstone AH, O'Driscoll A. Early AmBisome in febrile neutropenia in patients with haematological disorders. Bone Marrow Transplant 1994; 14 (Suppl. 5):S15-17.
24. Barwicz J, Gruda I, Tancrede P. A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins. FEBS Lett 2000; 465:83-6.
25. Barwicz J, Beauregard M, Tancrede P. Circular dichroism study of interactions of Fungizone or AmBisome forms of amphotericin B with human low density lipoproteins. Biopolymers 2002; 67:49-55.
26. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983; 8:1-16.
27. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000; 46:171-9.